Evidence map›Paper›PMID 29572325›Full record

Observational studyJournal of the American Heart Association2018

Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock: Findings From the 2013-2014 National Readmissions Database.

Ahmed N Mahmoud, Islam Y Elgendy, Mohammad K Mojadidi, Siddharth A Wayangankar, Anthony A Bavry, R David Anderson, Hani Jneid, Carl J Pepine

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. [Leuko-glycemic index in patients with ST elevation myocardial infarction].Revista medica del Instituto Mexicano del Seguro Social · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cardiogenic Shock.Journal of the American Heart Association · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ahmed N MahmoudDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL Ahmed.Mahmoud@medicine.ufl.edu.
Islam Y ElgendyDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
Mohammad K MojadidiDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
Siddharth A WayangankarDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
Anthony A BavryDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
R David AndersonDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
Hani JneidDivision of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX.
Carl J PepineDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL.
University of Florida · USBaylor College of Medicine · US

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
NCATS NIH HHS UL1 TR001427
6 · The paper itself

Abstract

backgroundPrior studies have shown that survivors of acute myocardial infarction (AMI) complicated by cardiogenic shock are likely to have increased risk of readmissions in the early post-discharge period. However, the contemporary prevalence, reasons, and predictors of 30-day readmissions are not well known. METHODS AND

resultsHospitalizations for a primary diagnosis of AMI complicated by cardiogenic shock, and discharged alive, were identified in the 2013 and 2014 Nationwide Readmissions Databases. Prevalence and reasons for 30-day unplanned readmissions were investigated. A hierarchical logistic regression model was used to identify independent predictors of 30-day readmissions. Among 1 116 933 patient hospitalizations with AMI, 39 807 (3.6%) had cardiogenic shock and were discharged alive. Their 30-day readmission rate was 18.6%, with a median time for readmission 10 days post discharge. Predictors of readmission included: non-ST-segment elevation myocardial infarction, female sex, low-income status, nonprivate insurance, chronic renal failure, long-term ventricular assist device or intra-aortic balloon placement, and tachyarrhythmia. The majority of readmissions were attributable to cardiac-related causes (52%); heart failure being the most frequent cardiac cause (39% of all cardiac causes). Noncardiac-related readmissions included infections (14.9%), bleeding (5.3%), and respiratory causes (4.9%). The median cost per readmission was $9473 US dollars ($5037-20 199).

conclusionsAmong survivors of AMI complicated by cardiogenic shock who were discharged from hospital, almost 1 in 5 are readmitted at 30 days, mainly because of cardiac reasons such as heart failure and new AMI. The risk of readmission was associated with certain baseline patient/hospital characteristics.

Indexed as

Patient ReadmissionAgedDatabases, FactualFemaleHealth StatusHospital CostsHumansMaleMyocardial InfarctionPatient DischargePrevalenceRecurrenceRisk AssessmentRisk FactorsShock, CardiogenicTime Factorscardiogenic shockheart failuremyocardial infarctionreadmission

Identifiers

PMID29572325
PMCPMC5907572
OpenAlexW2791730097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.